Advertisement

Ulcus-Therapie pp 256-268 | Cite as

Therapieziele beim peptischen Ulcus

  • K. H. Holtermüller
Conference paper
  • 10 Downloads
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Die Entscheidung zur Therapie einer Erkrankung beruht im wesentlichen auf der Abwägung von drei Faktoren: 1. dem natürlichen Krankheitsverlauf, 2. der Effektivität, diesen Krankheitsverlauf zu ändern, und 3. den Risiken und Kosten der Therapie. Die Kenntnis des natürlichen Krankheitsverlaufes erlaubt die Definition der therapeutischen Ziele. Die Wirksamkeit eines Behandlungsverfahrens, den natürlichen Krankheitsverlauf zu beeinflussen, und die Abwägung der Nebenwirkungen der Behandlung für den Patienten stellen die erforderliche, wissenschaftliche Grundlage für eine Entscheidung zur Behandlung dar.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Baume, P.E., Hunt, J.H., Piper, D.W.: Glycopyronium bromide in the treatment of chronic gastric ulcer. Gast oenterology 63, 399–406 (1972)Google Scholar
  2. 2.
    Binder, H.J., Cocco, A., Crossley, R. J., Finkelstein, W., Front, R., Friedmann, G., Groarke, J., Hughes, W., J Dhnson, A.F., McGuigan, J.E., Summers, R., Vlahcevic, R., Wilson, E.G., Winship, D.I Cimetidine in the treatment of duodenal ulcer. A multicentre double blind study, jastroenterology 74, 380–388 (1978)Google Scholar
  3. 3.
    Blum, A.L., Siewert, J.R., Palter, F.: Ulcustherapie mit Cimetidin. Dtsch. med. Wschr. 103, 135–139(1978)Google Scholar
  4. 4.
    Blum, A.L., Sonnenberg, A., Hess, A., Würsch, T.G., Walser, R., Koelz, H.R., Pelloni, S., Schmid, P.: Ulcer like sym)toms are specific but not sensitive signs of ulcer disease. Gastroenterology 74, 1116 1978) (abstract)Google Scholar
  5. 5.
    Bodemar, G., Walan, A.: Maintenance treatment of recurrent peptic ulcer byCimeti dine. Lancet 1978 1, 403–404PubMedCrossRefGoogle Scholar
  6. 6.
    Bonney, G.L.W., Pickering G.W.: Observation on the mechanism of pain in ulcer of stomach and duodenum. C in. Sci. 6, 63–111 (1948)Google Scholar
  7. 7.
    Bowers, J., Forbes, J., Freson, J.: Effect of nighttime anisotropine methyl bromide (AMB) on duodenal ulcer (DU) healing: a controlled trial. Gastroenterology 72, 1032 (1977) (abstract)Google Scholar
  8. 8.
    Christensen, E., Juhl, E., Tyi strup, N.: Treatment of duodenal ulcer. Randomized clinical trials of a decade (1964–1974). Gastroenterology 73, 1170–1178 (1977)PubMedGoogle Scholar
  9. 9.
    Cocking, J.B.: A trial of an ylopectin sulfate (SN-263) and propantheline bromide in the longterm treatment of hronic duodenal ulcer. Gastroenterology 62, 6–10 (1972)PubMedGoogle Scholar
  10. 10.
    Doll, R., Hill, LD., Hutton, F.C: Treatment of gastric ulcer with carbenoxolone sodium and oestrogens. Gut 6 19–24 (1965)PubMedCrossRefGoogle Scholar
  11. 11.
    Drugs for duodenal ulcer. Editorial. Lancet 1977 II, 1012–1013Google Scholar
  12. 12.
    Gheorghiu, Th., Frotz, H., Dole, A.: The therapeutic effect of carbenoxolone in duodenal ulcer. Preliminary an. lysis of a multi-centre double blind trial. Fourth Symposion on carbenoxolone, pp. 57–265. Mexico, London: Butterworth 1975Google Scholar
  13. 13.
    Gillespie, G., Gray, G.R., Smith, LS., Mackenzie, L, Crean, G.P.: Short term and maintenance Cimetidine treatmc it in severe duodenal ulceration. In: Cimetidine. Bur-land, W.L., Simkins, M.A. (eds.), pp. 240–247. Amsterdam, Oxford: Excerpta Medica 1977Google Scholar
  14. 14.
    Hampel, K.E., Billich, C., Dannenmeier, H. D., Fintelmann, V., Fischer, R., Schmid, E., Treske, U., Walz, A.: Therapie des Ulcus ventriculi et Ulcus duodeni mit Carbenoxolon-Natrium (Doppelblindversuch). Münch, med. Wschr. 114, 925–929 (1972)Google Scholar
  15. 15.
    Hollander, D., Harlan, J.: Antacids vs Placebos in peptic ulcer therapy. J. Amer. med. Ass. 226, 1181–1185(1973)CrossRefGoogle Scholar
  16. 16.
    Holtermüller, K.H., Bohlen, E., Castro, M., Weis, H.J.: Überlegungen zur Therapie mit Antacida. Med. Klin. 72, 1229–1241 (1977)PubMedGoogle Scholar
  17. 17.
    Ippoliti, A.F., Sturdevant, R.A.L., Isenberg, J. I., Binder, M., Camacho, R., Cano, R., Cooney, C., Kline, M.M., Koretz, R.L., Meyer, J.H., Samloff, M., Schwabe, A.D., Strom, E. A., Valenzuela, J. E., Wintroub, R.H.: Cimetidine versus intensive antacid therapy for duodenal ulcer. A multicenter study. Gastroenterology 74, 393–395 (1978)PubMedGoogle Scholar
  18. 18.
    Littman, A., Welch, R., Fruin, R.C., Aronson, A. R.: Controlled trials of aluminium hydroxide gels for peptic ulcer. Gastroenterology 73, 6–10 (1977)PubMedGoogle Scholar
  19. 19.
    Ludwig, H.: Behandlung von Ulcus ventriculi und Ulcus duodeni mit LS 519 - eine Doppelblindstudie. Therapiewoche 27, 1664–1670(1977)Google Scholar
  20. 20.
    Malchow, H., Sewing, K. F., Albinus, M., Horn, B., Schomerus, H., Dölle, W.: Cimetidin in der stationären Behandlung des peptischen Ulcus. I. Wirkung auf die Heilung des Ulcus duodeni. Dtsch. med. Wschr. 103, 149–152 (1978)Google Scholar
  21. 21.
    Multicentre Trial: The effect of Cimetidine on duodenal ulceration. In: Cimetidine. (Burland, W.L., Simkins, M. A., eds.), pp. 260–271. Amsterdam, Oxford: Excerpta Medica 1977Google Scholar
  22. 22.
    Multicentre Trial: Treatment of gastric ulcer by Cimetidine. In: Cimetidine. (Burland, W.L., Simkins, M.A., eds.), pp. 287–292. Amsterdam, Oxford: Excerpta Medica 1977Google Scholar
  23. 23.
    Patterson, T.L., Sandweiss, D.J.: The relationship between gastro-duodenal motility phases and symptoms associated with duodenal ulcer in the human. Amer. J. dig. Dis. 9, 375–392(1942)CrossRefGoogle Scholar
  24. 24.
    Peter, P., Gonvers, J. J., Pelloni, S., Weber, K., Sonnenberg, A., Strohmeyer, G., Hofstet-ter, J.R., Blum, A. L.: Cimetidine in the treatment of duodenal ulcer. In: International symposion on histamine-H2-receptor antagonists. (Creutzfeldt, W., ed.), pp. 190–199. Amsterdam, Oxford: Excerpta Medica 1978Google Scholar
  25. 25.
    Peterson, W.L., Sturdevant, R. A.L., Frankl, H.D., Richardson, C.T., Isenberg, J. I., Elashoff, J.D., Sones, J.Q., Gross, R.A., Mc Callum, R.W., Fordtran, J. W.: Healing of duodenal ulcer with an antacid regimen. New Engl. J. Med. 297, 341–345 (1977)PubMedCrossRefGoogle Scholar
  26. 26.
    Salmon, P. R., Brown, P., Williams, R., Read, H. E.: Evaluation of colloidal bismuth (De-nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Gut 15, 189–193(1974)Google Scholar
  27. 27.
    Saunders, J.H.B., Wormsley, K.G.: Long term effects and after effects of treatment of duodenal ulcer with metiamide. Lancet 1977 I, 765–767CrossRefGoogle Scholar
  28. 28.
    Scheurer, U., Witzel, L., Halter, F., Keller, H.-M., Huber, R., Galeazzi, R.: Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology 72, 838–841 (1977)PubMedGoogle Scholar
  29. 29.
    Semb, L.S., Berstad, A., Myren, J., Foss, J.Chr., Carlsen, E., Kruse-Jensen, A.: A double blind multicentre comparative study of Cimetidine and placebo in short-term treatment of active duodenal ulceration. In: Cimetidine. (Burland, W.L., Simkins, M.A., eds.), pp. 248–253. Amsterdam, Oxford: Excerpta Medica 1977Google Scholar
  30. 30.
    Sewing, K. F., Malchow, H., Albinus, M., Horn, B., Schomerus, H., Dölle, W.: Cimetidin in der stationären Behandlung des peptischen Ulcus. II. Doppelblindstudie bei Ulcus ventriculi. Dtsch. med. Wschr. 103, 152–154(1978)PubMedCrossRefGoogle Scholar
  31. 31.
    Soloway, R.D., Summerskill, W.H.J., Baggenstoss, A.H., Geall, M.G., Gitnick, G.L., Elveback, L.R., Schoenfield, L. J.: Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63, 820–833 (1972)PubMedGoogle Scholar
  32. 32.
    Sturdevant, R.A.L.: How should results of controlled trials affect clinical practice. Gastroenterology 75, 1179–1181 (1977)Google Scholar
  33. 33.
    Sturdevant, R.A.L., Isenberg, J.I., Secrist, D., Ansfield, J.: Antacid and placebo produced similar pain relief in duodenal ulcer patients. Gastroenterology 72, 1–5 (1977)PubMedGoogle Scholar
  34. 34.
    Sun, D.C., Ryan, M.L.: A controlled study on the use of propantheline and amylopectin sulfate (SN-263) for recurrences in duodenal ulcer. Gastroenterology 58, 756–761 (1970)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • K. H. Holtermüller

There are no affiliations available

Personalised recommendations